Tag Archives: Allergan v Sandoz

Allergan V. Sandoz – When Everything “Old” Is “New” Again

On Tuesday, a divided panel of the Fed. Cir. found that Allergan’s claimed method of reducing the number of daily topical doses of brimonidine to treat glaucoma from 3 to 2 doses by administering a composition containing 0.2% brimonidine and … Continue reading

Posted in Inherency | Tagged , , , , , , , , | Leave a comment